Condition: Chronic Obstructive Pulmonary Disease · Sponsor: Hoffmann-La Roche
The purpose of this study is to assess the long-term safety and to explore the efficacy of astegolimab in participants with chronic obstructive pulmonary disease (COPD) who have completed the 52-week placebo-controlled treatment period in parent studies GB43311 or GB44332.
This description comes directly from the study's public registry record.
Reference Study ID Number: GB43374 https://forpatients.roche.com/ No attachments to email below. · 888-662-6728 · global-roche-genentech-trials@gene.com
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Always discuss trial participation with your own doctor first.
| UAB Lung Health Center | Birmingham, Alabama, United States | Recruiting |
| SEC Clinical Research LLC - Dothan 2 - ClinEdge - PPDS | Dothan, Alabama, United States | Recruiting |
| Jasper Summit Research LLC | Jasper, Alabama, United States | Recruiting |
| Pulmonary Associates of Mobile PC | Mobile, Alabama, United States | Recruiting |
| Pulmonary Associates Deer Valley Office | Phoenix, Arizona, United States | Recruiting |
| AES - DRS - Synexus Clinical Research US, Inc. - Tucson | Tucson, Arizona, United States | Recruiting |
| Kern Allergy and Medical Research | Bakersfield, California, United States | Recruiting |
| Cadena Care Institute, LLC | Poway, California, United States | Recruiting |
| Apex Clinical Research | San Diego, California, United States | Completed |
| St Francis Medical Institute ClinEdge PPDS | Clearwater, Florida, United States | Recruiting |
| Finlay Medical Research Corporation | Greenacres City, Florida, United States | Recruiting |
| Flourish Research - Leesburg - PPDS | Leesburg, Florida, United States | Recruiting |
+ 474 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.